Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Stearns

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Experimental and Molecular Pathology|December 3, 2014
Crisp1 and alopecia areata in C3H/HeJ miceJohn P Sundberg, Alexander Awgulewitsch, Nathan D Pruett, et al.
Aging Cell|March 28, 2019
Glycine supplementation extends lifespan of male and female miceRichard A Miller, David E Harrison, C Michael Astle, et al.
Molecular Cancer Therapeutics|January 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma ModelsYifei Wang, Zhongting Zhang, Caterina Longo, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humansDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Aging Cell|March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sexDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Cell Reports|May 9, 2025
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 responseDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Nature Communications|June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivityIsabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Experimental and Molecular Pathology|December 3, 2014
Crisp1 and alopecia areata in C3H/HeJ miceJohn P Sundberg, Alexander Awgulewitsch, Nathan D Pruett, et al.
Aging Cell|March 28, 2019
Glycine supplementation extends lifespan of male and female miceRichard A Miller, David E Harrison, C Michael Astle, et al.
Molecular Cancer Therapeutics|January 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma ModelsYifei Wang, Zhongting Zhang, Caterina Longo, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humansDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Aging Cell|March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sexDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Cell Reports|May 9, 2025
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 responseDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Nature Communications|June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivityIsabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.
Pageof 4